Advancing the quality and safety of behavioural interventions in mental health research: A how-to guide from the MAGNET Clinical Trial Network
Adrienne O’Neil(Barwon Health), Michael Berk(The Royal Melbourne Hospital), Jessica Roydhouse(University of Tasmania), Ayla Barutchu(Barwon Health), Tayla John(Barwon Health), Madeleine L Connolly(Barwon Health), Erica Neill(The University of Melbourne), Philip J. Batterham(Mental Health Australia), Sean Carruthers(Swinburne University of Technology), Jessica A. Davis(Barwon Health), Christopher G. Davey(The University of Melbourne), Orli Schwartz(The University of Melbourne), Susan L. Rossell(St Vincent's Hospital Melbourne), Alyna Turner(Barwon Health), Josephine M. Chambers(Barwon Health), Katherine L. Mills(The University of Sydney), Rachel Fiddes(Barwon Health), Amelia Gulliver(Australian National University)
Cited by 3
Related Papers
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
So depression is an inflammatory disease, but where does the inflammation come from?
|BMC Medicine|2013|1.4k
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
|Bipolar Disorders|2012|1.2k
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754